Ruberg et al. recently published an article with the aim of starting a virtuous cycle in the use of Bayesian approaches in drug development (Nat. Rev. Drug Discov. 22, 235–250; 2023)¹. Here, we would like to extend important arguments of their article and add recommendations for using Bayesian statistics².

中文翻译：

---

药物开发中的贝叶斯方法：延续良性循环

Ruberg 等人最近发表了一篇文章，旨在开始在药物开发中使用贝叶斯方法的良性循环 （Nat. Rev. Drug Discov.22， 235–250;2023）¹.在这里，我们想扩展他们文章的重要论点，并添加使用贝叶斯统计² 的建议。